NextCure, Inc.
USD3.15
-0.25 (-7.35%)
CEO
Michael S. Richman
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.32
Prev. Close
$3.40
Day Low
$3.06
Day High
$3.48
52W Low
$2.83
52W High
$15.74
Market Cap
$0.01B
Volume
0.13M
| 14,670 |
| $10.85 |
| 3 Feb 2026 | Kundu Sourav | Sr VP, Dev. & Mfg. | A-Award | Acquired | 8,270 | $10.85 |
| 3 Feb 2026 | Mayer Timothy | Chief Operating Officer | A-Award | Acquired | 14,670 | $10.85 |
| 3 Feb 2026 | Richman Michael | director, officer: President & CEO | A-Award | Acquired | 38,190 | $10.85 |
| 3 Feb 2026 | Cobourn Steven P. | Chief Financial Officer | A-Award | Acquired | 14,670 | $10.85 |
| 19 Aug 2025 | Simcere Zaiming, Inc. | 10 percent owner | Disposed | 0 | $0.00 |
| 24 Jun 2025 | Houston John G | director | A-Award | Acquired | 18,700 | $0.47 |
| 24 Jun 2025 | Jones Elaine V | director | A-Award | Acquired | 18,700 | $0.47 |
| 24 Jun 2025 | KABAKOFF DAVID S | director | A-Award | Acquired | 28,050 | $0.47 |